Zoetis Inc. (NYSE:ZTS) Shares Purchased by Sumitomo Mitsui DS Asset Management Company Ltd

Sumitomo Mitsui DS Asset Management Company Ltd boosted its position in Zoetis Inc. (NYSE:ZTS - Free Report) by 7.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 94,921 shares of the company's stock after acquiring an additional 6,348 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd's holdings in Zoetis were worth $18,546,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Webster Bank N. A. lifted its stake in shares of Zoetis by 89.1% during the first quarter. Webster Bank N. A. now owns 174 shares of the company's stock worth $29,000 after purchasing an additional 82 shares in the last quarter. Quarry LP lifted its stake in shares of Zoetis by 273.2% during the second quarter. Quarry LP now owns 209 shares of the company's stock worth $36,000 after purchasing an additional 153 shares in the last quarter. LRI Investments LLC acquired a new position in shares of Zoetis during the first quarter worth about $43,000. Hazlett Burt & Watson Inc. lifted its stake in shares of Zoetis by 60.7% during the first quarter. Hazlett Burt & Watson Inc. now owns 270 shares of the company's stock worth $46,000 after purchasing an additional 102 shares in the last quarter. Finally, Central Valley Advisors LLC acquired a new position in shares of Zoetis during the second quarter worth about $49,000. Institutional investors and hedge funds own 92.80% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. Argus raised Zoetis to a "strong-buy" rating in a research report on Friday, August 9th. Piper Sandler lifted their target price on Zoetis from $195.00 to $210.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 14th. JPMorgan Chase & Co. lifted their target price on Zoetis from $225.00 to $230.00 and gave the stock an "overweight" rating in a research report on Friday, October 11th. Stifel Nicolaus lifted their target price on Zoetis from $200.00 to $210.00 and gave the stock a "buy" rating in a research report on Wednesday, September 18th. Finally, BTIG Research lifted their target price on Zoetis from $220.00 to $225.00 and gave the stock a "buy" rating in a research report on Monday, August 12th. Ten investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus target price of $221.44.

Zoetis Stock Up 1.2 %

Zoetis stock traded up $2.37 during midday trading on Friday, hitting $193.37. The stock had a trading volume of 1,576,373 shares, compared to its average volume of 2,526,615. The company has a current ratio of 3.45, a quick ratio of 2.09 and a debt-to-equity ratio of 1.32. The stock has a market cap of $88.23 billion, a P/E ratio of 37.26, a P/E/G ratio of 2.99 and a beta of 0.89. Zoetis Inc. has a 12 month low of $144.80 and a 12 month high of $201.92. The business has a fifty day moving average price of $188.98 and a 200 day moving average price of $176.99.

Zoetis (NYSE:ZTS - Get Free Report) last posted its earnings results on Tuesday, August 6th. The company reported $1.56 EPS for the quarter, beating the consensus estimate of $1.49 by $0.07. The company had revenue of $2.36 billion during the quarter, compared to analyst estimates of $2.31 billion. Zoetis had a return on equity of 50.67% and a net margin of 26.29%. The business's revenue was up 8.3% compared to the same quarter last year. During the same period in the prior year, the company earned $1.41 earnings per share. Research analysts predict that Zoetis Inc. will post 5.83 EPS for the current year.

Zoetis Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 3rd. Stockholders of record on Thursday, October 31st will be issued a dividend of $0.432 per share. This represents a $1.73 annualized dividend and a dividend yield of 0.89%. The ex-dividend date is Thursday, October 31st. Zoetis's dividend payout ratio (DPR) is presently 33.14%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.